Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,313,000 | 697,000 | 4,233,000 | 2,418,000 | 2,230,000 |
| Depreciation Amortization | 3,819,000 | 1,936,000 | 8,986,000 | 6,999,000 | 4,089,000 |
| Income taxes - deferred | -58,000 | 137,000 | -492,000 | -107,000 | -300,000 |
| Accounts receivable | -1,282,000 | 87,000 | -1,490,000 | -1,652,000 | -1,496,000 |
| Accounts payable and accrued liabilities | -392,000 | -1,594,000 | 951,000 | 1,549,000 | -181,000 |
| Other Working Capital | -4,661,000 | -1,944,000 | -2,365,000 | -1,889,000 | -3,046,000 |
| Other Operating Activity | 5,526,000 | 4,510,000 | 9,207,000 | 6,494,000 | 5,492,000 |
| Operating Cash Flow | $7,265,000 | $3,829,000 | $19,030,000 | $13,812,000 | $6,788,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -587,000 | -265,000 | -1,214,000 | -885,000 | -504,000 |
| Net Acquisitions | -1,090,000 | -266,000 | -5,441,000 | -4,280,000 | -1,478,000 |
| Purchase Of Investment | N/A | N/A | -35,000 | -29,000 | N/A |
| Sale Of Investment | N/A | N/A | 76,000 | 42,000 | N/A |
| Other Investing Activity | -94,000 | -43,000 | -29,000 | -28,000 | 66,000 |
| Investing Cash Flow | $-1,771,000 | $-574,000 | $-6,643,000 | $-5,180,000 | $-1,916,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -499,000 | -499,000 | 5,297,000 | 5,797,000 | 5,556,000 |
| Debt Issued | 7,991,000 | 7,991,000 | 3,994,000 | 3,994,000 | 3,994,000 |
| Debt Repayment | -2,000,000 | N/A | -6,797,000 | -6,789,000 | -6,780,000 |
| Common Stock Issued | N/A | N/A | 172,000 | 124,000 | N/A |
| Common Stock Repurchased | -1,498,000 | -1,489,000 | -980,000 | -977,000 | -973,000 |
| Dividend Paid | -6,156,000 | -3,086,000 | -11,657,000 | -8,746,000 | -5,835,000 |
| Other Financing Activity | -1,973,000 | -1,998,000 | -2,753,000 | -1,961,000 | 70,000 |
| Financing Cash Flow | $-4,135,000 | $919,000 | $-12,724,000 | $-8,558,000 | $-3,968,000 |
| Exchange Rate Effect | -19,000 | -12,000 | 42,000 | 31,000 | 39,000 |
| Beginning Cash Position | 5,229,000 | 5,229,000 | 5,524,000 | 5,524,000 | 5,524,000 |
| End Cash Position | 6,569,000 | 9,391,000 | 5,229,000 | 5,629,000 | 6,467,000 |
| Net Cash Flow | $1,340,000 | $4,162,000 | $-295,000 | $105,000 | $943,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,265,000 | 3,829,000 | 19,030,000 | 13,812,000 | 6,788,000 |
| Capital Expenditure | -587,000 | -265,000 | -1,214,000 | -885,000 | -504,000 |
| Free Cash Flow | 6,678,000 | 3,564,000 | 17,816,000 | 12,927,000 | 6,284,000 |